Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 3, 1996, Pages 163-168

  Vera Sempere, F J ^a   Burgos, J S ^a   Botella, M S ^a   Cordoba, J ^a   Gobernado, M ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

EBV; Immunohistochemistry; LMP 1; nested PCR; NPC

Indexed keywords

VIRUS ANTIGEN; VIRUS PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPAIN;

EID: 0029981049     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(95)00093-3     Document Type: Article

References (34)

1. Liebowitz D. Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin Oncol 1994, 21, 376-381.
2. Fingeroth JD, Weiss JJ, Tedder TF, et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sei USA 1984, 81, 4510-4514.
3. Sixbey JW, Nedrud JG, Raab-Traub N, et al. Epstein-Barr virus replication in oropharyngeal epithelial cells. N EnglJ Med 1984, 310, 1225-1230.
4. Sixbey JW, Yao O. Immunoglobulin A-induce shift of EpsteinBarr virus tissue tropism. Science 1992, 255, 1578-1580.
5. Niedobitek G, Young LS. Epstein-Barr virus persistence and virus-associated tumours. Lancet 1994, 343, 333-335.
6. Raab-Traub N, Flynn K, Pearson G, et al. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. IntJ Cancer 1987, 39, 25-29.
7. Pearson GB, Weiland L, Neel HB III, et al. Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinomas. Cancer 1983, 51,260-268.
8. Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in clinical specimens. AmJPathol 1994, 145, 239-252.
9. Hudson GS, Parrel PJ, Barrell BG. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. J Virol 1985, 53, 528-535.
10. Wang D, Leibowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985, 43, 831-840.
11. Rowe M, Evans HS, Young LS, Hennesy K, Kieff K, Rickinson AB. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J Gen Virol 1987, 68, 1575-1586.
12. Shanmugaratnam K, Sobin LH. Histological Typing of Upper Respiratorv Tract Tumours, International Histological Classification of Tumours, No. 19. Geneva: WHO, 1978.
13. U.I.C.C. TNM Atlas. Illustrated Guide to the TNMjpTNM Classification of Malignant Tumours. 3rd Edn, 2nd revision. Berlin, Springer, 1992.
14. Wood GS, Warnke R. Suppression of endogenous avidinbinding activity in tissues and its relevance to biotin-avidin detection systems. J Histochem Cytochem 1981, 29, 1196-1204.
15. Lauritzen AF, Hording U, Nielsen HW. Epstein-Barr virus and Hodgkin's disease. A comparative immunological, in situ hybridization and polymerase chain reaction study. APMIS 1994, 102, 495-500.
16. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1982.
17. Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds). PC R Protocols. A Guide to Methods and Applications. San Diego, CA, Academic Press, 1990.
18. Cinque P, Brytting M, Vago L, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993, 342, 398-401.
19. Telenti A, Marshall WF, Smith TF. Detection of Epstein-Barr virus by polymerase chain reaction. J Clin Microbiol 1990, 28, 2187-2190.
20. Hubbert A, De The G. Comportement alimentaire, modes de vie et cancer de rhinopharynx. Bull Cancer 1982, 69, 476-482.
21. Dickens P, Srivastava G, Loke SL, Chan CW, Liu YT. Epstein-Barr virus DNA in nasopharyngeal carcinomas from Chinese patients in Hong Kong. J Clin Pathol 1992, 45, 396-397.
22. Yeung WM, Zong YS, Chiu CT, et al. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 1993, 53, 746-750.
23. Herding U, Nielsen HW, Albeck H, Daugard S. Nasopharyngeal carcinoma : histopathological types and association with EpsteinBarr virus. Oral Oncol, Eur J Cancer 1993, 29B, 137-139.
24. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am y Pathol 1995, 146, 1355-1367.
25. Delia Torre G, Pilotti S, Donghi R, et al. Epstein-Barr virus genomes in undifferentiated and squamous cell nasopharyngeal carcinomas in Italian patients. Diagn Mol Pathol 1994, 3, 32-37.
26. Pallensen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991, 337, 320-322.
27. Fähraeus R, Fu HL, Ernberg I, et al. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988, 42, 329-338.
28. Young LS, Dawson CW, Clark D, et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988, 69, 1051-1065.
29. Niedobitek G, Young LS, Sam CK, Brooks L, Prasad U, Rickinson AB. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am J Pathol 1992, 140, 879-887.
30. Zheng X, Hu L, Chen F, Christensson B. Expression of Ki 67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP-1) in nasopharyngeal carcinoma. Oral Oncol, Eur J Cancer 1994, 30B, 290-295.
31. Hu LF, Chen F, Ernberg I, et al. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP-1. Oncogene 1993, 8, 1575-1583.
32. Trivedi P, Hu LF, Chen F, et al. Epstein-Barr(EBV)-encoded membrane protein LMP-1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. Eur J Cancer 1994, 30A, 84-88.
33. Hu LF, Minarovits J, Shi-Long C, et al. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region. J Virol 1991, 65, 1558-1567.
34. Jiwa NM, Oudejans JJ, Dükers DF, el al. Immunohistochemical demonstration of different latent membrane proteins-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases. J Clin Pathol 1995, 48, 438-442.